THE DIAGNOSTIC SIGNIFICANCE OF CRP AND OTHER MARKERS IN SUBCLINICAL INFLAMMATORY PROCESSES

Abstract

Subclinical inflammation is a low-grade, persistent immune activation that often remains asymptomatic but plays a crucial role in the development of chronic diseases such as cardiovascular disorders, metabolic syndrome, and type 2 diabetes. Laboratory markers, particularly C-reactive protein (CRP), interleukin-6 (IL‑6), and tumor necrosis factor-alpha (TNF‑α), provide essential tools for early detection and risk assessment. Monitoring these biomarkers enables timely preventive interventions, evaluation of therapeutic efficacy, and personalized patient management. The integration of laboratory data with clinical assessment enhances the ability to detect and manage hidden inflammatory processes, thereby improving health outcomes and reducing long-term complications. Understanding the diagnostic significance of these markers is vital for modern preventive medicine and clinical practice.